These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

579 related items for PubMed ID: 31111504

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Bmi-1 promotes the invasion and migration of colon cancer stem cells through the downregulation of E-cadherin.
    Zhang Z, Bu X, Chen H, Wang Q, Sha W.
    Int J Mol Med; 2016 Oct; 38(4):1199-207. PubMed ID: 27600678
    [Abstract] [Full Text] [Related]

  • 3. Effect of CD133 overexpression on the epithelial-to-mesenchymal transition in oral cancer cell lines.
    Moon Y, Kim D, Sohn H, Lim W.
    Clin Exp Metastasis; 2016 Jun; 33(5):487-96. PubMed ID: 27137188
    [Abstract] [Full Text] [Related]

  • 4. Identification of a subpopulation of long-term tumor-initiating cells in colon cancer.
    Peng L, Xiong Y, Wang R, Xiang L, Zhou H, Gu H.
    Biosci Rep; 2020 Aug 28; 40(8):. PubMed ID: 32729895
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer.
    Zhang Y, Wei J, Wang H, Xue X, An Y, Tang D, Yuan Z, Wang F, Wu J, Zhang J, Miao Y.
    Oncol Rep; 2012 May 28; 27(5):1599-605. PubMed ID: 22322379
    [Abstract] [Full Text] [Related]

  • 7. MiR-21 regulates epithelial-mesenchymal transition phenotype and hypoxia-inducible factor-1α expression in third-sphere forming breast cancer stem cell-like cells.
    Han M, Wang Y, Liu M, Bi X, Bao J, Zeng N, Zhu Z, Mo Z, Wu C, Chen X.
    Cancer Sci; 2012 Jun 28; 103(6):1058-64. PubMed ID: 22435731
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
    Geng S, Guo Y, Wang Q, Li L, Wang J.
    Arch Dermatol Res; 2013 Jan 28; 305(1):35-47. PubMed ID: 22740085
    [Abstract] [Full Text] [Related]

  • 10. Enrichment of colorectal cancer stem cells through epithelial-mesenchymal transition via CDH1 knockdown.
    Ye J, Wu D, Shen J, Wu P, Ni C, Chen J, Zhao J, Zhang T, Wang X, Huang J.
    Mol Med Rep; 2012 Sep 28; 6(3):507-12. PubMed ID: 22684815
    [Abstract] [Full Text] [Related]

  • 11. Discovery of VEGFR-2 inhibitors exerting significant anticancer activity against CD44+ and CD133+ cancer stem cells (CSCs): Reversal of TGF-β induced epithelial-mesenchymal transition (EMT) in hepatocellular carcinoma.
    Modi SJ, Kulkarni VM.
    Eur J Med Chem; 2020 Dec 01; 207():112851. PubMed ID: 33002846
    [Abstract] [Full Text] [Related]

  • 12. Epithelial-mesenchymal transition and cancer stem cell-like phenotype induced by Twist1 contribute to acquired resistance to irinotecan in colon cancer.
    Yang Y, Wang G, Zhu D, Huang Y, Luo Y, Su P, Chen X, Wang Q.
    Int J Oncol; 2017 Aug 01; 51(2):515-524. PubMed ID: 28627611
    [Abstract] [Full Text] [Related]

  • 13. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.
    Cho SH, Park YS, Kim HJ, Kim CH, Lim SW, Huh JW, Lee JH, Kim HR.
    Int J Oncol; 2012 Jul 01; 41(1):211-8. PubMed ID: 22552741
    [Abstract] [Full Text] [Related]

  • 14. Targeting Epithelial-Mesenchymal Transition for Identification of Inhibitors for Pancreatic Cancer Cell Invasion and Tumor Spheres Formation.
    Polireddy K, Dong R, McDonald PR, Wang T, Luke B, Chen P, Broward M, Roy A, Chen Q.
    PLoS One; 2016 Jul 01; 11(10):e0164811. PubMed ID: 27764163
    [Abstract] [Full Text] [Related]

  • 15. Expression of epithelial-mesenchymal transition and cancer stem cell markers in colorectal adenocarcinoma: Clinicopathological significance.
    Choi JE, Bae JS, Kang MJ, Chung MJ, Jang KY, Park HS, Moon WS.
    Oncol Rep; 2017 Sep 01; 38(3):1695-1705. PubMed ID: 28677737
    [Abstract] [Full Text] [Related]

  • 16. Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells.
    Han M, Liu M, Wang Y, Mo Z, Bi X, Liu Z, Fan Y, Chen X, Wu C.
    Mol Cell Biochem; 2012 Apr 01; 363(1-2):427-36. PubMed ID: 22187223
    [Abstract] [Full Text] [Related]

  • 17. CRISPR-Cas9 mediated CD133 knockout inhibits colon cancer invasion through reduced epithelial-mesenchymal transition.
    Li W, Cho MY, Lee S, Jang M, Park J, Park R.
    PLoS One; 2019 Apr 01; 14(8):e0220860. PubMed ID: 31393941
    [Abstract] [Full Text] [Related]

  • 18. Suppression of colorectal cancer metastasis by nigericin through inhibition of epithelial-mesenchymal transition.
    Zhou HM, Dong TT, Wang LL, Feng B, Zhao HC, Fan XK, Zheng MH.
    World J Gastroenterol; 2012 Jun 07; 18(21):2640-8. PubMed ID: 22690072
    [Abstract] [Full Text] [Related]

  • 19. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.
    Leng Z, Xia Q, Chen J, Li Y, Xu J, Zhao E, Zheng H, Ai W, Dong J.
    Cell Physiol Biochem; 2018 Jun 07; 46(2):860-872. PubMed ID: 29627827
    [Abstract] [Full Text] [Related]

  • 20. Exosome-mediated delivery of functionally active miRNA-375-3p mimic regulate epithelial mesenchymal transition (EMT) of colon cancer cells.
    Rezaei R, Baghaei K, Amani D, Piccin A, Hashemi SM, Asadzadeh Aghdaei H, Zali MR.
    Life Sci; 2021 Mar 15; 269():119035. PubMed ID: 33450254
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.